Geode Capital Management
CRHM

Geode Capital Management’s CRH Medical Corporation CRHM Stock Holding History

Geode Capital Management’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-24,600
Closed -$201K – 4128
2017
Q1 		$201K Buy
+24,600
New +$170K ﹤0.01% 3650

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

Geode Capital Management's CRHM Position: Q2 2017 in Review

Geode Capital Management sold out of CRH Medical Corporation (CRHM) in Q2 2017, closing a stake of 24,600 shares — an estimated $201K sold.

Geode Capital Management first reported a position in CRHM in Q1 2017 and held it in 1 quarter. The position peaked at $201K in Q1 2017. 59 funds tracked by Wall St. Rank hold CRHM as of Q2 2017.

  • Geode Capital Management reported no remaining CRH Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • Geode Capital Management sold 24,600 CRH Medical Corporation shares in Q2 2017, an estimated $201K.
  • Geode Capital Management first reported a position in CRH Medical Corporation in Q1 2017 and held it in 1 quarter.
  • Geode Capital Management's CRH Medical Corporation position peaked at $201K in Q1 2017.
  • 59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2017.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.